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Background: We hypothesized that a high resting heart rate (HR) and low systolic systemic blood pressure (SBP) would portend a worse prognosis 
in patients with pulmonary arterial hypertension (PAH), similar to patients with left ventricular dysfunction. We tested this hypothesis by analyzing 
survival and freedom from all-cause hospitalization (hosp) in the Registry to Evaluate Early And Long-term PAH Disease Management (REVEAL), a 
large ongoing prospective US-based observational study.
Methods: For each of 3 baseline variables, HR, SBP, and the ratio SBP/HR, patients age ≥ 19 at enrollment were divided into quintiles (Q). Kaplan 
Meier curves were calculated by Q for survival and for freedom from hosp. The results for Q2-4 were similar and were combined in the final analysis. 
Log-rank analysis with a Bonferroni correction was used to assess differences.
Results: The baseline 6 minute walk distance, right heart pressures and cardiac output were similar across Q of all 3 vital sign variables. The table 
shows mean ± SE percent survival and freedom from hosp at 1 year, with p values for comparisons to Q2-4.
*P<0.01
**P<0.001
Q1
Q2-4
Q5
SBP ≤102
>102 to ≤130
>130
HR ≤70
>70 to ≤95
>95
SBP/HR ≤1.2
>1.2 to ≤1.7
> 1.7
N 2693 2666 2657
Survival
Q1
Q2-4
Q5
86 ± 2 **
91 ± 1
91 ± 1
92 ± 1
91 ± 1
86 ± 2 **
84 ± 2 **
91 ± 1
92 ± 1
Freedom from
hospitalization
Q1
Q2-4
Q5
63 ± 2 **
72 ± 1
74 ± 2
73 ± 2
72 ± 1
63 ± 2 *
61 ± 2 **
72 ± 1
76 ± 2
Conclusions: In a large cohort of PAH patients, baseline HR, SBP, and SBP/HR predicted survival and freedom from hospitalization during the first 
year of follow-up despite the similarity of some traditional prognostic indicators in PAH across Q. Vital sign parameters HR > 95, SBP ≤ 102, or the 
ratio of SBP/HR ≤ 1.2 identified a high risk group of patients that might benefit from more intensive treatment.
